Medicare Enrolled
Dr. Howard Benn, MD
Optician · Paterson, NJ
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Consulting-driven
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Benn from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Benn?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Benn
Dr. Howard Benn is an optician specialist in Paterson, NJ, with 19 years of NPI registration. Based on federal Medicare data, Dr. Benn performed 999 Medicare services across 453 unique beneficiaries.
Between the years covered by Open Payments, Dr. Benn received a total of $27,061 from 76 pharmaceutical and/or device companies across 789 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Benn is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ 999 Medicare services
$27,061 industry payments
Medicare Practice Summary
Medicare Utilization ↗999
Medicare services
Bottom 49% in NJ for optician
453
Unique beneficiaries
$93
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~53 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
374 | $69 | $160 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
347 | $106 | $240 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
65 | $78 | $165 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
54 | $151 | $445 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
48 | $104 | $230 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
37 | $147 | $325 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
31 | $50 | $100 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
29 | $129 | $365 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
14 | $100 | $240 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$27,061
Total received (2018-2024)
Avg $3,866/year across 7 years
Top 5% in NJ for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
76
Companies
789
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$13,491 (49.9%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,744 (43.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,826 (6.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,405
2023
$2,369
2022
$4,323
2021
$5,997
2020
$1,343
2019
$2,712
2018
$7,911
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$367
E.R. Squibb & Sons, L.L.C.
$213
Janssen Biotech, Inc.
$212
PFIZER INC.
$180
Merck Sharp & Dohme LLC
$180
Novartis Pharmaceuticals Corporation
$122
Aveo Pharmaceuticals, Inc.
$115
Takeda Pharmaceuticals U.S.A., Inc.
$109
Bayer Healthcare Pharmaceuticals Inc.
$100
Celgene Corporation
$96
Astellas Pharma US Inc
$70
Eisai Inc.
$69
Daiichi Sankyo Inc.
$67
Tempus AI, Inc
$59
EMD Serono, Inc.
$45
Adaptive Biotechnologies Corporation
$44
TAIHO ONCOLOGY, INC.
$36
Genentech USA, Inc.
$31
PUMA BIOTECHNOLOGY, INC.
$31
Medtronic, Inc.
$30
Emmaus Medical, Inc.
$28
Acrotech Biopharma Inc.
$23
Dendreon Pharmaceuticals LLC
$20
Gilead Sciences, Inc.
$20
Exelixis Inc.
$19
Blueprint Medicines Corporation
$18
ARRAY BIOPHARMA INC
$17
ABBVIE INC.
$17
Sumitomo Pharma America, Inc.
$17
Pharmacosmos Therapeutics Inc.
$16
Incyte Corporation
$16
JAZZ PHARMACEUTICALS INC.
$15
Top 3 companies account for 32.9% of 2024 payments
All-time payments by company (2018-2024) ›
INSYS Therapeutics Inc
$6,581
E.R. Squibb & Sons, L.L.C.
$3,343
Global Blood Therapeutics, Inc.
$3,022
AstraZeneca Pharmaceuticals LP
$1,461
Puma Biotechnology, Inc.
$1,129
Amgen Inc.
$1,083
Novartis Pharmaceuticals Corporation
$893
Celgene Corporation
$673
Janssen Biotech, Inc.
$597
Bayer HealthCare Pharmaceuticals Inc.
$554
Daiichi Sankyo Inc.
$547
Genentech USA, Inc.
$491
Merck Sharp & Dohme Corporation
$476
Merck Sharp & Dohme LLC
$472
Seagen Inc.
$412
PFIZER INC.
$390
Sirtex Medical Inc
$375
Takeda Pharmaceuticals U.S.A., Inc.
$351
Eisai Inc.
$316
Lilly USA, LLC
$271
Incyte Corporation
$243
Medtronic, Inc.
$235
Astellas Pharma US Inc
$228
Bayer Healthcare Pharmaceuticals Inc.
$221
Gilead Sciences, Inc.
$215
Exelixis Inc.
$194
EISAI INC.
$172
Boehringer Ingelheim Pharmaceuticals, Inc.
$145
Kite Pharma, Inc.
$135
Emmaus Medical, Inc.
$124
Aveo Pharmaceuticals, Inc.
$115
Regeneron Healthcare Solutions, Inc.
$97
GENZYME CORPORATION
$96
Adaptive Biotechnologies Corporation
$91
Myovant Sciences Inc.
$88
EMD Serono, Inc.
$72
Mirati Therapeutics, Inc.
$66
Janssen Scientific Affairs, LLC
$63
Tempus AI, Inc
$59
Acrotech Biopharma LLC
$59
Rigel Pharmaceuticals, Inc.
$58
Ipsen Biopharmaceuticals, Inc
$52
Sunovion Pharmaceuticals Inc.
$47
MACROGENICS, INC.
$44
ABBVIE INC.
$43
GlaxoSmithKline, LLC.
$39
Dendreon Pharmaceuticals LLC
$37
Sumitomo Pharma America, Inc.
$36
TAIHO ONCOLOGY, INC.
$36
Blueprint Medicines Corporation
$32
ARRAY BIOPHARMA INC
$32
PUMA BIOTECHNOLOGY, INC.
$31
Pharmacosmos Therapeutics Inc.
$30
Pharmacyclics LLC, An AbbVie Company
$30
Epizyme, Inc.,
$25
G1 Therapeutics, Inc.
$24
Seattle Genetics, Inc.
$23
Acrotech Biopharma Inc.
$23
Secura Bio, Inc.
$18
Sobi, Inc
$18
Horizon Therapeutics plc
$17
BeiGene USA, Inc.
$16
PharmaEssentia USA Corporation
$16
CTI BioPharma Corp.
$15
West Therapeutics Development, LLC
$15
JAZZ PHARMACEUTICALS INC.
$15
AbbVie Inc.
$15
Servier Pharmaceuticals LLC
$15
SERVIER PHARMACEUTICALS LLC
$15
Jazz Pharmaceuticals Inc.
$14
Janssen Pharmaceuticals, Inc
$13
Alexion Pharmaceuticals, Inc.
$13
Alnylam Pharmaceuticals Inc.
$13
Novocure Inc.
$13
AVEO Pharmaceuticals, Inc.
$12
Karyopharm Therapeutics Inc.
$12
Top 3 companies account for 47.8% of all-time payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · AFINITOR · ALIMTA · ALUNBRIG · AYVAKIT · Abraxane · Alecensa · Aliqopa · Avastin · BELEODAQ · BENLYSTA · BESREMI · BOSULIF · BRAFTOVI · BRUKINSA · Blincyto · CABOMETYX · CALQUENCE · CARVYKTI · CHANTIX · COSELA · CREON · CYRAMZA · DARZALEX · DOPTELET · ELIQUIS · EMPLICITI · ENHERTU · ERLEADA · EVENITY · Endari · Enhertu · FARYDAK · FOLOTYN · FOTIVDA · FRUZAQLA · Fabhalta · GAZYVA · GILOTRIF · GIVLAARI · Halaven · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INPEN SMART INSULIN DELIVERY SYSTEM · Imbruvica · JADENU · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · KRYSTEXXA · Kadcyla · Kyprolis · LENVIMA · LIBTAYO · LINZESS · LONHALA MAGNAIR · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lazanda · Lenvima · MARGENZA · MEKINIST · MINIMED 780G · MONJUVI · MONOFERRIC · NINLARO · Nerlynx · Neulasta · Nexavar · Nplate · Nubeqa · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Optune · PADCEV · PIQRAY · PROMACTA · PROVENGE · Padcev · Perjeta · Polivy · Pomalyst · REBLOZYL · RETEVMO · RYBREVANT · RYDAPT · Revlimid · Rezlidhia · SARCLISA · SCEMBLIX · SIGNIA · SIR-Spheres Microspheres · SOMATULINE DEPOT · SPRYCEL · SYNDROS · Stivarga · TABRECTA · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TEPMETKO · TIBSOVO · TUKYSA · Tavalisse · Trodelvy · Turalio · ULTOMIRIS · VELCADE · VENCLEXTA · VERZENIO · VPRIV · VYXEOS · Vectibix · Venclexta · Vitrakvi · Vonjo · Vyloy · XALKORI · XARELTO · XPOVIO · XT CDX · Xofigo · Xospata · Xtandi · ZEJULA · ZEPZELCA · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (50%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 5% for optician in NJ.
Geographic Context
Opticians within 10 mi
13,093
Per 100K population
2526.2
County median income
$87,137
Nearest hospital
ST JOSEPH'S UNIVERSITY MEDICAL CENTER INC
1.9 mi
1.9 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Benn is a clinical cardiology specialist, with moderate Medicare volume, with consulting-driven industry engagement in the top 5% of NJ peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Benn experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Benn performed 374 hospital follow-up visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Benn receive payments from pharmaceutical companies?
Yes. Dr. Benn received a total of $27,061 from 76 companies across 789 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Benn's costs compare to other opticians in Paterson?
Dr. Benn's average Medicare payment per service is $93. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Benn) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Paterson
Browse opticians in Paterson ranked by procedure volume and transparency data.
Highest volume
Top Opticians in NJ
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in NJ
Which NJ opticians receive the most from drug and device companies.
By company
INSYS Therapeutics Inc Payments to Doctors
See all physicians who received payments from INSYS Therapeutics Inc.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
Global Blood Therapeutics, Inc. Payments to Doctors
See all physicians who received payments from Global Blood Therapeutics, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology